Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Neurovirol. 2019 Nov 19;26(2):155–167. doi: 10.1007/s13365-019-00809-z

Table 1.

Demographic and clinical information for HIV− and HIV+ adults

Variable HIV+ (n = 307) HIV− (n = 183) p
Age (years) 49.6 (12.2) 47.7 (15.7) 0.667
Gender (% men) 85.7 67.2 < 0.0001
Handedness (% right) 91.2 89.1 0.438
Education (years) 13.6 (2.5) 14.2 (2.6) 0.031
Hollingshead Highest Occupation 5.6 (1.7) 5.6 (1.8) 0.704
Race/Ethnicity (%) 0.148
 Caucasian 57.3 59.1
 African American 22.8 16.9
 Hispanic 17.9 19.1
 Other 2.0 4.9
Major Depressive Disorder (%) < 0.0001
 Current 13.7 3.3
 Lifetime 62.9 33.9
Generalized Anxiety Disorder (%) < 0.0001
 Current 4.9 0.0
 Lifetime 17.9 3.8
Substance Use Disorder (%)b 73.0 59.6 0.002
Global Deficit Score (GDS) e 0.23 (0, 0.54) 0.15 (0, 0.33) 0.005
Medical
 Hepatitis C Infection (HCV,%) 22.3 10.4 0.001
 Estimated duration of infection (years) 15.8 (9.5) --
 Plasma HIV RNA (rnlog10) a 1.6 (1.6, 1.7) --
 Current CD4 count (cells/μL) a 583 (400, 784) --
 Nadir CD4 count (cells/μL) a 186 (63, 300) --
 AIDS (%) 57.7 --
 Antiretroviral therapy (% prescribed) 90.2 --

Note. Data represent M (SD) or valid population % values. HIV = Human Immunodeficiency Virus; CD4 = cluster of differentiation.

a

Based on median and interquartile range (IQR) scores

b

Based on lifetime prevalence (no participants met criteria for current Substance Use Disorder)